查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1360308

癌症诊断市场中的人工智慧 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

AI in Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 153 Pages | 商品交期: 2-10个工作天内

价格

癌症诊断市场中的人工智慧 - 报告范围

TMR 关于全球癌症诊断市场人工智慧的报告研究了过去以及当前的成长趋势和机会，以获得2023 年至2031 年预测期内市场指标的宝贵见解。该报告提供了全球人工智慧在癌症诊断市场中的营收2017-2031 年癌症诊断市场，以 2023 年为基准年，2031 年为预测年。该报告也提供了2023年至2031年全球人工智慧在癌症诊断市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解癌症诊断市场中的人工智慧。

市场概况
2023年市场价值 8.59 亿美元
2031 年市场价值 20 亿美元
复合年增长率 11.2%

该报告深入探讨了全球人工智慧在癌症诊断市场的竞争格局。全球癌症诊断市场人工智慧的主要参与者已经确定，并且每位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球癌症诊断市场人工智慧参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 肿瘤学中机器学习的不同技术概述
  • 技术进步
  • 用作的主要软体列表
  • 按地区/全球分類的监管情景
  • COVID-19 大流行对产业的影响（价值炼和短期/中期/长期影响）

第 6 章：全球市场分析与预测：按组成部分

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按组成部分，2017-2031
    • 软体解决方案
    • 服务
  • 市场吸引力分析：按组成部分

第 7 章：全球市场分析与预测：按癌症类型

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按癌症类型，2017-2031
    • 乳癌
    • 摄护腺癌
    • 肺癌
    • 大肠直肠癌
    • 子宫颈癌
    • 其他的
  • 市场吸引力分析：按癌症类型

第 8 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 筛检与诊断
    • 肿瘤识别
    • 监控
  • 市场吸引力分析：按应用

第 9 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院
    • 诊断中心
    • 医学研究机构
    • 合约研究组织
  • 市场吸引力分析：按最终用户

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者-竞争矩阵：依公司层级与规模划分
  • 市占率分析：依公司划分，2022 年
  • 公司简介
    • Ibex Medical Analytics
    • EarlySign
    • Cancer Center.ai
    • Microsoft
    • Flatiron
    • Path AI
    • Therapixel
    • Tempus
    • Paige AI, Inc.
    • Kheiron Medical Technologies Limited
    • SkinVision
    • Freenome
    • Whiterabbit.ai
    • Mindpeak GmbH
Product Code: TMRGL85783

AI in Cancer Diagnostics Market - Scope of Report

TMR's report on the global AI in cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global AI in cancer diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global AI in cancer diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the AI in cancer diagnostics market.

Market Snapshot
Market Value in 2023US$ 859 Mn
Market Value in 2031US$ 2 Bn
CAGR11.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global AI in cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global AI in cancer diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global AI in cancer diagnostics market.

The report delves into the competitive landscape of the global AI in cancer diagnostics market. Key players operating in the global AI in cancer diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global AI in cancer diagnostics market profiled in this report.

Key Questions Answered in Global AI in Cancer Diagnostics Market Report:

  • What is the sales/revenue generated by AI in cancer diagnostics across all regions during the forecast period?
  • What are the opportunities in the global AI in cancer diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

AI in Cancer Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global AI in cancer diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global AI in cancer diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global AI in cancer diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global AI in Cancer Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Component Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global AI in Cancer Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Different Technique Overview of Machine Learning in Oncology
  • 5.2. Technological Advancements
  • 5.3. List of Major Software used as AI in Cancer Diagnostics
  • 5.4. Regulatory Scenario by Region/Globally
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Component

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Component, 2017-2031
    • 6.3.1. Software Solutions
    • 6.3.2. Services
  • 6.4. Market Attractiveness Analysis, by Component

7. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Cancer Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 7.3.1. Breast Cancer
    • 7.3.2. Prostate Cancer
    • 7.3.3. Lung Cancer
    • 7.3.4. Colorectal Cancer
    • 7.3.5. Cervical Cancer
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Cancer Type

8. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Screening & Diagnosis
    • 8.3.2. Tumor Identification
    • 8.3.3. Monitoring
  • 8.4. Market Attractiveness Analysis, by Application

9. Global AI in Cancer Diagnostics Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Medical Research Institutes
    • 9.3.4. Contract Research Organizations
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global AI in Cancer Diagnostics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America AI in Cancer Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Component, 2017-2031
    • 11.2.1. Software Solutions
    • 11.2.2. Services
  • 11.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 11.3.1. Breast Cancer
    • 11.3.2. Prostate Cancer
    • 11.3.3. Lung Cancer
    • 11.3.4. Colorectal Cancer
    • 11.3.5. Cervical Cancer
    • 11.3.6. Others
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Screening & Diagnosis
    • 11.4.2. Tumor Identification
    • 11.4.3. Monitoring
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Centers
    • 11.5.3. Medical Research Institutes
    • 11.5.4. Contract Research Organizations
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Component
    • 11.7.2. By Cancer Type
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe AI in Cancer Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Component, 2017-2031
    • 12.2.1. Software Solutions
    • 12.2.2. Services
  • 12.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 12.3.1. Breast Cancer
    • 12.3.2. Prostate Cancer
    • 12.3.3. Lung Cancer
    • 12.3.4. Colorectal Cancer
    • 12.3.5. Cervical Cancer
    • 12.3.6. Others
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Screening & Diagnosis
    • 12.4.2. Tumor Identification
    • 12.4.3. Monitoring
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Centers
    • 12.5.3. Medical Research Institutes
    • 12.5.4. Contract Research Organizations
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Component
    • 12.7.2. By Cancer Type
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific AI in Cancer Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Component, 2017-2031
    • 13.2.1. Software Solutions
    • 13.2.2. Services
  • 13.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 13.3.1. Breast Cancer
    • 13.3.2. Prostate Cancer
    • 13.3.3. Lung Cancer
    • 13.3.4. Colorectal Cancer
    • 13.3.5. Cervical Cancer
    • 13.3.6. Others
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Screening & Diagnosis
    • 13.4.2. Tumor Identification
    • 13.4.3. Monitoring
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Centers
    • 13.5.3. Medical Research Institutes
    • 13.5.4. Contract Research Organizations
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Component
    • 13.7.2. By Cancer Type
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America AI in Cancer Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Component, 2017-2031
    • 14.2.1. Software Solutions
    • 14.2.2. Services
  • 14.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 14.3.1. Breast Cancer
    • 14.3.2. Prostate Cancer
    • 14.3.3. Lung Cancer
    • 14.3.4. Colorectal Cancer
    • 14.3.5. Cervical Cancer
    • 14.3.6. Others
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Screening & Diagnosis
    • 14.4.2. Tumor Identification
    • 14.4.3. Monitoring
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Centers
    • 14.5.3. Medical Research Institutes
    • 14.5.4. Contract Research Organizations
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Component
    • 14.7.2. By Cancer Type
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa AI in Cancer Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Component, 2017-2031
    • 15.2.1. Software Solutions
    • 15.2.2. Services
  • 15.3. Market Value Forecast, by Cancer Type, 2017-2031
    • 15.3.1. Breast Cancer
    • 15.3.2. Prostate Cancer
    • 15.3.3. Lung Cancer
    • 15.3.4. Colorectal Cancer
    • 15.3.5. Cervical Cancer
    • 15.3.6. Others
  • 15.4. Market Value Forecast, by Application, 2017-2031
    • 15.4.1. Screening & Diagnosis
    • 15.4.2. Tumor Identification
    • 15.4.3. Monitoring
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Diagnostic Centers
    • 15.5.3. Medical Research Institutes
    • 15.5.4. Contract Research Organizations
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Component
    • 15.7.2. By Cancer Type
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix, by tier and size of companies
  • 16.2. Market Share Analysis, by Company, 2022
  • 16.3. Company Profiles
    • 16.3.1. Ibex Medical Analytics
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. EarlySign
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Cancer Center.ai
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Microsoft
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Flatiron
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Path AI
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Therapixel
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Tempus
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Paige AI, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Kheiron Medical Technologies Limited
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. SkinVision
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Freenome
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Whiterabbit.ai
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. Mindpeak GmbH
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview

List of Tables

  • Table 01: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 02: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 03: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 07: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 08: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 11: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 12: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 13: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 17: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 18: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 22: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 23: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Component, 2017-2031
  • Table 27: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Table 28: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 29: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 02: Global AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 03: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Software Solutions, 2017-2031
  • Figure 04: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Services, 2017-2031
  • Figure 05: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Cancer Type, 2017-2031
  • Figure 06: Global AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 07: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
  • Figure 08: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031
  • Figure 09: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Lung Cancer, 2017-2031
  • Figure 10: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031
  • Figure 11: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Cervical Cancer, 2017-2031
  • Figure 12: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 13: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Figure 14: Global AI in Cancer Diagnostics Market Attractiveness Analysis, Application, 2023-2031
  • Figure 15: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Screening & Diagnosis, 2017-2031
  • Figure 16: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Tumor Identification, 2017-2031
  • Figure 17: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Monitoring, 2017-2031
  • Figure 18: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Figure 19: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Figure 20: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 21: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Diagnostic Centers, 2017-2031
  • Figure 22: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Medical Research Institutes, 2017-2031
  • Figure 23: Global AI in Cancer Diagnostics Market Revenue (US$ Mn), by Contract Research Organizations, 2017-2031
  • Figure 24: Global AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Figure 25: Global AI in Cancer Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 27: North America AI in Cancer Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 28: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 29: North America AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 30: North America AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 31: North America AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 32: North America AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031
  • Figure 33: North America AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 34: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: North America AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 36: North America AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 37: Europe AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 38: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 40: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 41: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 42: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 43: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 44: Europe AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 45: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 46: Europe AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 47: Europe AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 48: Asia Pacific AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 50: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 51: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 52: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 53: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 54: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Cancer Type, 2023-2031
  • Figure 55: Asia Pacific AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 56: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 57: Asia Pacific AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Latin America AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 60: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 62: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 63: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 64: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031
  • Figure 65: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 66: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 67: Latin America AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 68: Latin America AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 69: Middle East & Africa AI in Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 70: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 71: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 72: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Component, 2022 and 2031
  • Figure 73: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, Component, 2023-2031
  • Figure 74: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Cancer Type, 2022 and 2031
  • Figure 75: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, Cancer Type, 2023-2031
  • Figure 76: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 77: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 78: Middle East & Africa AI in Cancer Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 79: Middle East & Africa AI in Cancer Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 80: Global AI in Cancer Diagnostics Market Share Analysis, by Company 2022